Susan E. Kirk, MSPAS, PA-C


  • Texas Medical Center


Blood Disorders

Phone: 832-822-1320
Fax: 832-825-4362

Contact Information

1102 Bates Ave., Ste. 1580
Houston, TX 77030
United States

Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine


School Education Degree Year
University of Kentucky, College of Health Sciences university Physician Assistant 2008
Mississippi State University university Biological Engineering


Susan Kirk has been treating children with blood disorders for over 10 years. She is a member of the immune hematology, general hematology, and hematosis and thrombosis teams. Susan treats children with many conditions including anemias, low blood counts and bleeding and clotting disorders. She is particularly interested in immune thrombocytopenia (ITP) and bone marrow failure disorders. Susan works with the hematology teams in clinical trials, including therapies for ITP and aplastic anemia. Susan's goals are to have her patients and famillies understand their diagnosis and treatment options and to help them navigate all of the aspects of their care.

Her primary clinical interests include immune mediated hematologic conditions, particularly immune thrombocytopenia (ITP) and autoimmune hemolytic anemia (AIHA). She also has clinical interest in general hematologic conditions including nutritional anemias, enzyme deficiencies, membranopathies, and hemoglobinopathies.


Organization Name Role
American Academy of Physician Assistants (AAPA) Member
American Society of Pediatric Hematology/Oncology (ASPHO) Member
National Hemophilia Foundation Member

Research Statement

Susan Kirk’s research interest is focused on immune thrombocytopenia (ITP) and the study of novel agents to treat this condition. Susan is actively involved in expanding access to diagnostic tools and life-saving treatments for sickle cell disease in the U.S. and internationally through the Texas Children’s Center for Global Health. Susan spends much of her time at international sites supporting global projects in areas where the burden of sickle cell disease is greatest.